Metabolic syndrome and risk of subsequent colorectal cancer.

The metabolic syndrome and visceral obesity have an increasing prevalence and incidence in the general population. The actual prevalence of the metabolic syndrome is 24% in US population and between 24.6% and 30.9% in Europe. As demonstrated by many clinical trials (NAHANES III, INTERHART) the metabolic syndrome is associated with an increased risk of both diabetes and cardiovascular disease. In addition to cardiovascular disease, individual components of the metabolic syndrome have been linked to the development of cancer, particularly to colorectal cancer. Colorectal cancer is an important public health problem; in the year 2000 there was an estimated total of 944,717 incident cases of colorectal cancer diagnosed world-wide. This association is sustained by many epidemiological studies. Recent reports suggest that individuals with metabolic syndrome have a higher risk of colon or rectal cancer. Moreover, the clusters of metabolic syndrome components increase the risk of associated cancer. The physiopathological mechanism that links metabolic syndrome and colorectal cancer is mostly related to abdominal obesity and insulin resistance. Population and experimental studies demonstrated that hyperinsulinemia, elevated C-peptide, elevated body mass index, high levels of insulin growth factor-1, low levels of insulin growth factor binding protein-3, high leptin levels and low adiponectin levels are all involved in carcinogenesis. Understanding the pathological mechanism that links metabolic syndrome and its components to carcinogenesis has a major clinical significance and may have profound health benefits on a number of diseases including cancer, which represents a major cause of mortality and morbidity in our societies.

• Publication year

  2009

• Venue

  World Journal of Gastroenterology

• Publication date

  2009-11-07

• Fields of study

  Medicine

• Identifiers
  DOI 10.3748/WJG.15.5141PMID 19891012PMCID PMC2773892
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence and trends in obesity among US adults, 1999-2008.

  2010cited by this paper
• Components of the metabolic syndrome and colorectal cancer risk; a prospective study

  2008cited by this paper
• Metabolic syndrome: prevalence, associated factors, and C-reactive protein: the MADRIC (MADrid RIesgo Cardiovascular) Study.

  2008cited by this paper
• Expression of Peroxisome Proliferator-Activated Receptor-γ in Colon Cancer: Correlation with Histopathological Parameters, Cell Cycle-Related Molecules, and Patients’ Survival

  2007cited by this paper
• Peroxisome proliferator-activated receptor γ agonists inhibit the proliferation and invasion of human colon cancer cells

  2007cited by this paper
• Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study

  2007influential reference
• Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer

  2007cited by this paper
• Peroxisome proliferator-activated receptor gamma agonists inhibit the proliferation and invasion of human colon cancer cells.

  2007cited by this paper
• Leptin Concentrations, Leptin Receptor Polymorphisms, and Colorectal Adenoma Risk

  2007influential reference
• Prognostic significance of adiponectin levels in non-metastatic colorectal cancer.

  2007cited by this paper
• Adiponectin in relation to malignancies: a review of existing basic research and clinical evidence.

  2007cited by this paper
• Leptin and leptin receptor genotypes and colon cancer: Gene–gene and gene–lifestyle interactions

  2007cited by this paper
• The metabolic syndrome and risk of incident colorectal cancer

  2006influential reference
• The metabolic syndrome: A high-risk state for cancer?

  2006cited by this paper
• Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC).

  2006cited by this paper
• C-Peptide, Insulin-like Growth Factor Binding Protein-1, Glycosylated Hemoglobin, and the Risk of Distal Colorectal Adenoma in Women

  2006influential reference
• Association of Visceral Fat Accumulation and Plasma Adiponectin with Colorectal Adenoma: Evidence for Participation of Insulin Resistance

  2005cited by this paper
• Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications.

  2005cited by this paper
• The metabolic syndrome: a global public health problem and a new definition.

  2005cited by this paper
• Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

  2005cited by this paper
• The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

  2005cited by this paper
• Leptin Is Associated with an Increased Female Colorectal Cancer Risk: A Nested Case-Control Study in Japan

  2005cited by this paper
• Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.

  2005cited by this paper
• Metabolic syndrome.

  2005cited by this paper
• Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

  2005cited by this paper
• Adiponectin Inhibits Cell Proliferation by Interacting with Several Growth Factors in an Oligomerization-dependent Manner*

  2005cited by this paper
• Acromegaly and Cancer

  2005cited by this paper
• The metabolic syndrome: time for a critical appraisal

  2005cited by this paper
• The metabolic syndrome: prevalence in worldwide populations.

  2004cited by this paper
• Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

  2004cited by this paper
• Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer-Norfolk study.

  2004cited by this paper
• Association of the Metabolic Syndrome With History of Myocardial Infarction and Stroke in the Third National Health and Nutrition Examination Survey

  2004cited by this paper
• A prospective study of plasma C-peptide and colorectal cancer risk in men.

  2004influential reference
• BMI and waist circumference as predictors of lifetime colon cancer risk in Framingham Study adults

  2004cited by this paper
• Obesity, adipocytokines, and insulin resistance in breast cancer

  2004cited by this paper
• Obesity and colon cancer: Does leptin provide a link?

  2004cited by this paper
• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

  2004cited by this paper
• A novel pathway to the manifestations of metabolic syndrome.

  2004cited by this paper
• Lipase‐Specific Foldases

  2004cited by this paper
• Role of oxygen radicals in DNA damage and cancer incidence

  2004cited by this paper
• Association of markers of insulin and glucose control with subsequent colorectal cancer risk.

  2003cited by this paper
• The metabolic syndrome.

  2003cited by this paper
• Serum interleukin‐6 levels reflect the disease status of colorectal cancer

  2003cited by this paper
• Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults.

  2003influential reference
• Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer.

  2002cited by this paper
• Prevalence and trends in obesity among US adults, 1999-2000.

  2002influential reference
• Epidemiology of colorectal cancer.

  2002cited by this paper
• Colorectal cancer mortality and factors related to the insulin resistance syndrome.

  2002cited by this paper
• Transient Hyperproliferation of a Transgenic Human Epidermis Expressing Hepatocyte Growth Factor

  2002cited by this paper
• Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis.

  2001cited by this paper
• Markers of insulin resistance and colorectal cancer mortality.

  2001cited by this paper
• A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women.

  2000cited by this paper
• Increased p53-dependent apoptosis by the insulin-like growth factor binding protein IGFBP-3 in human colonic adenoma-derived cells.

  2000cited by this paper
• Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.

  2000cited by this paper
• Role of insulin‐like growth factors and their binding proteins in growth control and carcinogenesis

  2000cited by this paper
• Increased blood glucose and insulin, body size, and incident colorectal cancer.

  1999cited by this paper
• Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

  1999cited by this paper
• Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3

  1999cited by this paper
• Induction of Vascular Endothelial Growth Factor by Insulin-like Growth Factor 1 in Colorectal Carcinoma*

  1996cited by this paper
• Physical Activity, Obesity, and Risk for Colon Cancer and Adenoma in Men

  1995cited by this paper
• [Epidemiology of colorectal cancer].

  1991cited by this paper
• The cancer experience in the framingham heart study cohort

  1991cited by this paper
• Regulation of intestinal epithelial cell growth by transforming growth factor type beta.

  1989cited by this paper
• Cancer Incidence in Five Continents

  1970cited by this paper
• [Not Available].

  1947cited by this paper
• 0021-972X/04/$15.00/0 The Journal of Clinical Endocrinology & Metabolism 89(6):2563–2568 Printed in U.S.A. Copyright © 2004 by The Endocrine Society doi: 10.1210/jc.2004-0518 Adiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function

  year unknowncited by this paper
• Regulation of intestinal epithelial cell growth by transforming growth factor type (1

  year unknowncited by this paper

• The Influence of Metabolic Syndrome on the Development of Gastrointestinal Malignant Tumors—A Review

  2025cites this paper
• Association between proteinuria changes and colorectal cancer incidence: evidence from a nationwide cohort study

  2025cites this paper
• Epidemiology of colonic adenoma and cancer.

  2025cites this paper
• Obesity and Inflammatory Factors in the Progression of Early-Onset Colorectal Cancer

  2024cites this paper
• comorbidPGS: An R Package Assessing Shared Predisposition between Phenotypes Using Polygenic Scores

  2024cites this paper
• Presentation, Molecular Characteristics, Treatment, and Outcomes of Colorectal Cancer in Patients Older than 80 Years Old

  2023cites this paper
• Risk of colorectal adenocarcinoma in men receiving androgen deprivation therapy for prostate cancer; a nationwide cohort study

  2023cites this paper
• Association between metabolic syndrome and gastric cancer risk: results from the Health Examinees Study

  2023cites this paper
• The short- and long-term readmission of four major categories of digestive system cancers: does obesity or metabolic disorder matter?

  2023cites this paper
• The feasibility of a telephone-based weight loss intervention in rural Ohio: A pilot study

  2023cites this paper
• Tartary Buckwheat Flavonoids Improve Colon Lesions and Modulate Gut Microbiota Composition in Diabetic Mice

  2022cites this paper
• Association between oral cavity cancer and metabolic syndrome

  2022cites this paper
• Relation of the Metabolic Syndrome to Incident Colorectal Cancer in Young Adults Aged 20 to 49 Years.

  2021cites this paper
• The Link between Cancer, Autoimmunity and Diabetes

  2021cites this paper
• Association of Adiponectin and Vitamin D With Tumor Infiltrating Lymphocytes and Survival in Stage III Colon Cancer

  2021cites this paper
• Adiponectin: Structure, Physiological Functions, Role in Diseases, and Effects of Nutrition

  2021cites this paper
• Effect of Metabolic Syndrome and Individual Components on Colon Cancer Characteristics and Prognosis

  2021cites this paper
• Association of Metabolic Syndrome and Cardiovascular Risk factors Among Colorectal Cancer Patients Attending in Tikur Anbessa Specialized Hospital Oncology Units : A comparative cross-sectional study

  2020cites this paper
• The effect of metabolic syndrome on head and neck cancer incidence risk: a population-based prospective cohort study

  2020cites this paper
• Coenzyme Q10 and Metabolic Syndrome

  2020cites this paper
• O-GlcNAcylation Links Nutrition to the Epigenetic Downregulation of UNC5A during Colon Carcinogenesis

  2020cites this paper
• Investigation of the Risk Factors and Associated Co-Morbid Conditions among Patients with Colorectal Cancer in Trinidad

  2020cites this paper
• IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405

  2020cites this paper
• A saturated fatty acid-rich diet enhances hepatic lipogenesis and tumorigenesis in HCV core gene transgenic mice.

  2020cites this paper
• Food groups, diet quality and colorectal cancer risk in the Basque Country

  2020cites this paper
• Coenzyme Q in Aging

  2020cites this paper
• Metabolic syndrome and risk of pancreatic cancer: A population‐based prospective cohort study

  2020cites this paper
• The relationship between metabolic syndrome and the incidence of colorectal cancer

  2020cites this paper
• Acarbose improved survival for Apc+/Min mice

  2020cites this paper
• Metabolic syndrome is a risk factor for colorectal adenoma and cancer: a study in a White population using the harmonized criteria

  2019cites this paper
• ADIPONECTIN, VITAMIN D AND NUTRITIONAL STATUS IN PATIENTS WITH ADVANCED COLORECTAL CANCER OR DURING FOLLOW-UP.

  2019cites this paper
• Diabetes, Obesity, and the Metabolic Syndrome as Prognostic Factors in Stages I to III Colorectal Cancer Patients

  2019cites this paper
• A novel leptin receptor antagonist uncouples leptin’s metabolic and immune functions

  2019cites this paper
• Association between the prevalence of metabolic syndrome and coffee consumption among Korean adults: results from the Health Examinees study.

  2019cites this paper
• Leptin Level Variance in Adults With and Without Cancer

  2019cites this paper
• Clinical pharmacists in chronic care

  2019cites this paper
• The effect of omentin-1 on the proliferation and apoptosis of colon cancer stem cells and the potential mechanism.

  2019cites this paper
• How the association between obesity and inflammation may lead to insulin resistance and cancer.

  2019cites this paper
• Nonalcoholic steatohepatitis is associated with a higher risk of advanced colorectal neoplasm

  2019cites this paper
• Suppressive effects of the sodium‑glucose cotransporter 2 inhibitor colorectal tumorigenesis in diabetic and obese mice

  2019cites this paper
• Effects of Obstructive Sleep Apnea-Hypopnea Syndrome on Serum Carcinoembryonic Antigen Levels in Patients with Type 2 Diabetes Mellitus

  2019cites this paper
• Microsatellite instability is inversely associated with type 2 diabetes mellitus in colorectal cancer

  2019cites this paper
• Association between High Levels of Circulating Chemerin and Colorectal Adenoma in Men

  2019cites this paper
• Clinical Depression, Antidepressant Use, and Metabolic Syndrome-related Comorbidities among Canadian Older Adults: A Cross-sectional Analysis of Baseline Data from the Canadian Longitudinal Study of Aging

  2019cites this paper
• Metabolic Syndrome Components Correlation with Colorectal Neoplasms: A Systematic Review and a Meta-analysis

  2018cites this paper
• Clinical trials of kimchi intakes on the regulation of metabolic parameters and colon health in healthy Korean young adults

  2018cites this paper
• The Leptin Receptor Complex: Heavier Than Expected?

  2017cites this paper
• MicroRNA-mediated MMP Regulation: Current Diagnostic and Therapeutic Strategies for Metabolic Syndrome.

  2017cites this paper
• Adipocytes activate mitochondrial fatty acid oxidation and autophagy to promote tumor growth in colon cancer

  2017cites this paper
• Height and body fatness and colorectal cancer risk: an update of the WCRF–AICR systematic review of published prospective studies

  2017cites this paper
• Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice

  2017cites this paper
• The influence of metabolic syndrome in the outcomes of colorectal cancer patients.

  2017influential citation
• Glucose Oncometabolism of Esophageal Cancer.

  2017cites this paper
• Diets link metabolic syndrome and colorectal cancer development (Review).

  2017cites this paper
• Clinical update on metabolic syndrome

  2017cites this paper
• The in fl uence of metabolic syndrome in the outcomes of colorectal cancer patients

  2017influential citation
• Function and Dysfunction of Adipose Tissue.

  2017cites this paper
• INVESTIGATION OF THE INFLAMMATORY AND PROTHROMBOTIC HEMATOLOGICAL INDICES IN THE PATIENTS WITH METABOLIC SYNDROME

  2017cites this paper
• Potential Benefit of Metformin as Treatment for Colon Cancer: the Evidence so Far.

  2016cites this paper
• Silencing the Nucleocytoplasmic O-GlcNAc Transferase Reduces Proliferation, Adhesion, and Migration of Cancer and Fetal Human Colon Cell Lines

  2016cites this paper
• Modified metabolic syndrome and second cancers in women: A case control study

  2016cites this paper
• 3’UTR Polymorphism in ACSL1 Gene Correlates with Expression Levels and Poor Clinical Outcome in Colon Cancer Patients

  2016cites this paper
• Association between severity of plaque psoriasis and metabolic syndrome

  2016cites this paper
• Genetic Variants in the Insulin-like Growth Factor Pathway and Colorectal Cancer Risk in the Netherlands Cohort Study

  2015cites this paper
• The Joint Effects of Lifestyle Factors and Comorbidities on the Risk of Colorectal Cancer: A Large Chinese Retrospective Case-Control Study

  2015cites this paper
• Absence of non-alcoholic fatty liver disease in the presence of insulin resistance is a strong predictor for colorectal carcinoma.

  2015cites this paper
• Glycation and Hypoxia: Two Key Factors for Adipose Tissue Dysfunction.

  2015cites this paper
• Diabetes mellitus and colorectal cancer – a revealed connection

  2015cites this paper
• Prediagnostic Plasma Adiponectin and Survival among Patients with Colorectal Cancer

  2015cites this paper
• Body size, physical activity, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk.

  2015cites this paper
• 3’-UTR Polymorphisms in the MiRNA Machinery Genes DROSHA, DICER1, RAN, and XPO5 Are Associated with Colorectal Cancer Risk in a Korean Population

  2015cites this paper
• Metabolic predispositions and increased risk of colorectal adenocarcinoma by anatomical location: a large population-based cohort study in Norway.

  2015cites this paper
• Metabolic syndrome and risk of cancer: which link?

  2015influential citation
• Impact of high glucose on metastasis of colon cancer cells.

  2015cites this paper
• Leptin: From structural insights to the design of antagonists.

  2015cites this paper
• Relationships of colorectal cancer with dietary factors and public health indicators: an ecological study.

  2015cites this paper
• Application of emulsion-based delivery system to enhance bioavailability and efficacy of tangeretin

  2014cites this paper
• Functional modification of adipocytes by grape seed extract impairs their pro-tumorigenic signaling on colon cancer stem cells and the daughter cancer cells

  2014cites this paper
• Predicting the occurrence of cancer-associated colorectal polyp using a metabolic risk score.

  2014cites this paper
• Genes associated with metabolic syndrome predict disease‐free survival in stage II colorectal cancer patients. A novel link between metabolic dysregulation and colorectal cancer

  2014influential citation
• New perspectives on β-catenin control of cell fate and proliferation in colon cancer.

  2014cites this paper
• O-GlcNAcylation, an Epigenetic Mark. Focus on the Histone Code, TET Family Proteins, and Polycomb Group Proteins

  2014cites this paper
• The role of metabolic syndrome and related clinical variables in determining CEA levels.

  2014cites this paper
• Improvement of the Quality, Health Promoting and Performance Enhancement Attributes of Combat Rations

  2014cites this paper
• The micronutrient profile of the typical American diet enhances colorectal carcinogenesis in mice (123.4)

  2014cites this paper
• Inhibitory effects of astaxanthin on azoxymethane-induced colonic preneoplastic lesions in C57/BL/KsJ-db/db mice

  2014influential citation
• The Diabetes-Cancer Link

  2014cites this paper
• Prevalence of metabolic syndrome in colorectal cancer patients - Effects of a diet and lifestyle intervention

  2014cites this paper
• [Obesity and components of metabolic syndrome in Mexican women survivors of cancer].

  2014cites this paper
• Cancer Council Australia Essay Competition for Medical Students “Ageing and Cancer – Individualised care for the Ageing population”

  2014cites this paper
• Molecular Pathology and Diagnostics of Colorectal Cancer

  2014cites this paper
• Development of a 28-Day Kimchi Cyclic Menu for Health

  2014cites this paper
• Colorectal cancer risk and dyslipidemia: a case-cohort study nested in an Italian multicentre cohort.

  2014cites this paper
• Antagonizing leptin: current status and future directions

  2014cites this paper
• Nonalcoholic Fatty Liver Disease and Extra-hepatic Malignancy

  2014cites this paper
• Interplay between 3′-UTR polymorphisms in the vascular endothelial growth factor (VEGF) gene and metabolic syndrome in determining the risk of colorectal cancer in Koreans

  2014cites this paper
• Development of an OP9 Derived Cell Line as a Robust Model to Rapidly Study Adipocyte Differentiation

  2014cites this paper
• Effect of a high-fat diet in development of colonic adenoma in an animal model.

  2014cites this paper
• Physiological functions of peroxisome proliferator-activated receptor β.

  2014cites this paper
• Putative Role of Adipose Tissue in Growth and Metabolism of Colon Cancer Cells

  2014influential citation